FDA to tighten phenobarbital, chlordiazepoxide scheduling in September

The Food and Drug Administration (FDA) announced Saturday that all compound drugs containing phenobarbital and chlordiazepoxide will be classed as Schedule 4 controlled substances by default under new rules set to be implemented in September.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)